Showing results (161-170 of 348) with videos related to
Sort By:
Pageof 35
Molecular Neurodegeneration|April 9, 2022
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degenerationAlba Cervantes González, David J Irwin, Daniel Alcolea, et al.Oncotarget|September 24, 2015
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controlsFrederic Sampedro, Eduard Vilaplana, Mony J de Leon, et al.Alzheimer'S Research & Therapy|July 5, 2025
Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinicJavier Arranz, Rosa Ferrer, Nuole Zhu, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2025
Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's diseasePrzemysław R Kac, Daniel Alcolea, Laia Montoliu-Gaya, et al.Journal of Alzheimer'S Disease : JAD|February 8, 2014
Posttranslational nitro-glycative modifications of albumin in Alzheimer's disease: implications in cytotoxicity and amyloid-β peptide aggregationEva Ramos-Fernández, Marta Tajes, Ernest Palomer, et al.Biomolecules|April 12, 2020
Kynurenic Acid Levels are Increased in the CSF of Alzheimer's Disease PatientsMarta González-Sánchez, Javier Jiménez, Arantzazu Narváez, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 4, 2020
Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderlyJordi Pegueroles, Adriana Pané, Eduard Vilaplana, et al.JAMA Network Open|August 5, 2022
Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down SyndromeLaura Videla, Bessy Benejam, Jordi Pegueroles, et al.Journal of Neuroscience Research|June 29, 2022
Myelin loss in C9orf72 hexanucleotide expansion carriersSònia Sirisi, Marta Querol-Vilaseca, Oriol Dols-Icardo, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2023
Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndromeLaura Videla, Bessy Benejam, María Carmona-Iragui, et al.Pageof 35